Another possible reason is that the sample size of our study is still relatively small; if more breast cancer patients with brain metastasis are included, the effect of cytoplasmic HDAC3 on post‐brain metastatic survival may become statistically significant. This evidence concerns the gene HDAC3 and breast carcinoma.